Our findings also revealed that IL6 expression was not changed under short-term insulin exposure; assuming that IL6 elevation may start during the early phases of insulin resistance (and hyperinsulinemia), longer exposure of insulin is needed to elevate IL6 expression, and treatment with different medications in vitro has a differential impact compared to in vivo administration. Here, INS is linked to Insulin resistance.